Bibliometric Analysis
Journal Bibliometric Report (2021)
The Journal Bibliometric Report is based on all publications in Medline/Pubmed that were cited by Medline/Pubmed publications in 2021.
Journals for Psychopharmacology
For each journal, the table below lists the year of the most recent citable publication (Last Year); the total number of times citable publications were cited in 2021 (Total Cites); the average number of times citable publications from 2019 and 2020 were cited by publications in 2021 (Impact Factor); the average number of times citable publications from 2016 through 2020 were cited by publications in 2021 (5-Year Impact); the average number of times citable publications from 2021 were cited by publications in 2021 (Immediacy Index); the number of citable publications in 2021 (Articles); and the median age in years of citable publications that were cited by publications in 2021 (Cited Half-Life). Citable publications are those whose Medline/Pubmed type is "Journal Article", which in general includes things like original research, meta-analysis, and reviews, but does not include editorials or letters. The data in the table below includes self-citations.
| Rank | Journal | Last Year | Total Cites | Impact Factor | 5-Year Impact | Immediacy Index | Articles | CitedHalfLife | JournalDetails |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Adv Biochem Psychopharmacol | 1995 | 43 | 0.000 | 0.000 | 0.000 | 0 | 41 | Details |
| 2 | Cannabis Cannabinoid Res | 2024 | 872 | 2.681 | 4.422 | 0.391 | 110 | 3 | Details |
| 3 | Clin Neuropharmacol | 2024 | 1130 | 0.584 | 0.691 | 0.063 | 63 | 11 | Details |
| 4 | Curr Dev Psychopharmacol | 1981 | 2 | 0.000 | 0.000 | 0.000 | 0 | 42 | Details |
| 5 | Essent Psychopharmacol | 2006 | 7 | 0.000 | 0.000 | 0.000 | 0 | 16 | Details |
| 6 | Eur Neuropsychopharmacol | 2024 | 4808 | 2.413 | 2.452 | 0.610 | 154 | 7 | Details |
| 7 | Exp Clin Psychopharmacol | 2024 | 1728 | 1.419 | 1.569 | 0.388 | 103 | 8 | Details |
| 8 | Harm Reduct J | 2024 | 1403 | 2.729 | 2.721 | 0.483 | 120 | 3 | Details |
| 9 | Hum Psychopharmacol | 2024 | 1038 | 0.947 | 1.196 | 0.362 | 47 | 9 | Details |
| 10 | Int Clin Psychopharmacol | 2024 | 1058 | 1.034 | 1.035 | 0.268 | 41 | 12 | Details |
| 11 | Int J Neuropsychopharmacol | 2024 | 4508 | 2.717 | 3.030 | 1.388 | 85 | 7 | Details |
| 12 | J Child Adolesc Psychopharmacol | 2024 | 1783 | 1.564 | 1.574 | 0.151 | 73 | 6 | Details |
| 13 | J Clin Psychopharmacol | 2024 | 2324 | 0.886 | 1.180 | 0.333 | 93 | 11 | Details |
| 14 | J Psychoactive Drugs | 2024 | 1348 | 1.721 | 1.513 | 0.306 | 72 | 8 | Details |
| 15 | J Psychopharmacol | 2024 | 4775 | 2.199 | 2.564 | 0.707 | 123 | 7 | Details |
| 16 | Mod Probl Pharmacopsychiatry | 1997 | 120 | 0.000 | 0.000 | 0.000 | 0 | 34 | Details |
| 17 | Mod Trends Pharmacopsychiatry | 2017 | 77 | 0.000 | 1.500 | 0.000 | 0 | 6 | Details |
| 18 | Neuropsychopharmacol Hung | 2023 | 58 | 0.265 | 0.198 | 0.059 | 17 | 9 | Details |
| 19 | Neuropsychopharmacol Rep | 2024 | 252 | 1.442 | 1.336 | 1.333 | 60 | 1 | Details |
| 20 | Neuropsychopharmacology | 2024 | 19750 | 3.954 | 4.494 | 0.907 | 258 | 8 | Details |
| 21 | Nihon Shinkei Seishin Yakurigaku Zasshi | 2017 | 40 | 0.000 | 0.231 | 0.000 | 0 | 13 | Details |
| 22 | Nord J Psychiatry | 2024 | 1307 | 0.829 | 1.044 | 0.153 | 98 | 8 | Details |
| 23 | Pharmacol Biochem Behav | 2024 | 6776 | 1.720 | 1.787 | 0.398 | 113 | 14 | Details |
| 24 | Pharmacopsychiatry | 2024 | 965 | 1.170 | 1.533 | 0.355 | 31 | 11 | Details |
| 25 | Prog Neuropsychopharmacol Biol Psychiatry | 2024 | 7916 | 2.478 | 2.666 | 0.953 | 192 | 7 | Details |
| 26 | Psychopharmacol Bull | 2024 | 840 | 0.727 | 0.924 | 0.467 | 30 | 30 | Details |
| 27 | Psychopharmacol Ser | 1993 | 7 | 0.000 | 0.000 | 0.000 | 0 | 33 | Details |
| 28 | Psychopharmacology (Berl) | 2024 | 13847 | 2.325 | 2.294 | 0.487 | 279 | 11 | Details |
| 29 | Psychopharmacology Suppl | 1985 | 4 | 0.000 | 0.000 | 0.000 | 0 | 37 | Details |
| 30 | Yakubutsu Seishin Kodo | 1993 | 7 | 0.000 | 0.000 | 0.000 | 0 | 31 | Details |